Becker's World of the Cell (9th Edition)
9th Edition
ISBN: 9780321934925
Author: Jeff Hardin, Gregory Paul Bertoni
Publisher: PEARSON
expand_more
expand_more
format_list_bulleted
Concept explainers
Videos
Textbook Question
Chapter 26, Problem 1Q
Monoclonal antibodies directed against the CD20 antigen are used to treat certain forms of lymphoma. However, the CD20 antigen is present on both mature normal and malignant lymphocytes, and treatment with the antibody therefore kills normal cells as well as cancer cells. Why do you think this antibody still turns out to be an effective treatment for lymphoma?
Expert Solution & Answer
Want to see the full answer?
Check out a sample textbook solution
Students have asked these similar questions
CD8 T cells in a culture are analyzed for their ability to produce the cytokine IFN-g, and the numbers of IFN-g-producing CD8 T cells are quantified. As a control, T cells are also stimulated with an irrelevant non-viral peptide (ova) plus dendritic cells. The results are shown in the figure below. Why is the T cell response different between the two lymph node populations?
Please could you explain how lymphocytes (especially B) can maintain
receptors on their surfaces? Is this genetically related? If so, when the
lymphocytes are first exposed to the antigens, how could the antigen
receptor be synthesized?
Is there a mutation within the nuclei of these lymphocytes when they
learn to make the receptors? If there is, can you explain how this occurs?
How do T cells, NK cells and macrophages recognize and destroy cells? How do cancer cells protect themselves from these cells? Explain how monoclonal antibodies and CAR-T-cells are used in cancer therapy. What are the advantages of these therapies?
Chapter 26 Solutions
Becker's World of the Cell (9th Edition)
Ch. 26 - As you will learn later in this chapter, cancer...Ch. 26 - Prob. 26.2CCCh. 26 - Although tobacco smoking is responsible for a...Ch. 26 - Prob. 26.4CCCh. 26 - Monoclonal antibodies directed against the CD20...Ch. 26 - Patients who have received organ transplants...Ch. 26 - Prob. 26.1PSCh. 26 - Phorbol Esters and Cancer. The active ingredient...Ch. 26 - Angiogenesis. Describe two pieces of evidence...Ch. 26 - Prob. 26.4PS
Knowledge Booster
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, biology and related others by exploring similar questions and additional content below.Similar questions
- picture 1 shows the directed migration of two immune cell types, neutrophils (red) and macrophages (green) to a laser-induced injury in the ear of a mouse. As you can observe from the video, there are three stages to this process: 1) an initial phase characterized by fast recruitment of neutrophils (red) to the site of injury followed by 2) the slower recruitment of macrophages after which 3) the interaction between both cell types is stabilized. Recruitment to the injury site is mediated by leukotriene B4 (LTB4), a potent immune signaling molecule (Figure 1A). LTB4 binds to BLT1, a G-protein coupled receptor (GPCR), activating various signaling pathways and resulting in immune cell migration to the site of injury (Figure 1B). With this background information and your knowledge of cell and molecular biology, describe in detail in your own words, as many molecular processes as you can identify that must take place for the cell migration process depicted in the video to be achieved. For…arrow_forwardResearchers can make monoclonal antibodies by immunizing a mouse with a molecule (or with a microorganism). The resulting antibody-mediated response produces a set of antibodies that recognize different parts of the molecule. The mouse's B cells are then harvested from its spleen and fused with cancerous B cells from a myeloma cell line. The resulting hybrid myeloma ("hybridoma") cells are cloned: Individual cells are grown in tissue culture as separate cell lines. Each cell line produces and secretes antibodies that recognize one part of the immunizing molecule. These antibodies are called monoclonal antibodies, and they can be purified and used for research or other purposes. Monoclonal antibodies are effective for passive immunization, but only in the immediate term. Antibodies produced by one's own immune system can last up to about six months in the bloodstream, but monoclonals delivered in passive immunization often last for less than a week. Why the difference?arrow_forwardTumour associated macrophages (TAMS) represent up to 50% of cells in solid tumours. Explain how these cells contribute to immunosuppression in the tumour microenvironment and how they help tumour cells to evade anti-tumour immune responsesarrow_forward
- 2. A 65-year-old man has a carcinoma. Study of the neoplasm shows absence of class I MHC molecules and no tumor-specific antigens. An immunologic response from which of the following cells is most likely to lyse some tumor cells? OA) B lymphocytes B) y6-T lymphocytes OC) CD8+ T lymphocytes D) Macrophages OE) Natural killer cellsarrow_forwardThe current view in the field of immunology is that dendritic cells are the primary antigen-presenting cells for stimulating naive T cells. One piece of evidence supporting this conclusion is the observation that IRF8-deficient individuals, which retain their tissue-resident macrophages, are susceptible to a range of severe opportunistic infections caused by intracellular bacteria, viruses, and fungi. Explain the reasoning behind this argument.arrow_forward1:Describe the various stages of T cells and the events that occur during each of these stages during T cell development. What stages of T cell development would be affected in mice with the following genetic mutations? Justify your answer. a) Mice that do not express MHC Class I molecule. b) Mice that do not express Rag1 c) Mice that do not express the pre-T-alpha chain 2:Transgenic mice that have constitutive expression of Rag1/2 are being used in an experiment to study pre-BCR signaling. Based on your knowledge of early B cell development, speculate on what might be the fate of BCR rearrangement and how will this affect further development of B cells in the bone marrow? please answer in full detail I want long well explained answers.arrow_forward
- Cellular immunity develops from a single stem cell called the multipotent hematopoietic stem cell. Select all of the mature, effector cell types found in the blood of a typical adult human that develop from these stem cells in the bone marrow. ✓ B cell ✔ NK cell ✓basophil ✔eosinophil dendritic cell ✔macrophage ✓ T cell ✔ILC ✔ mast cell ✔neutrophil ✔erythrocytearrow_forwardT cells can differentiate into 5 different subsets of helper T cells. Answer the following questions for TH1 cells: A) In general, list three unique factors that differentiate the TH1 subset from the other subsets. B) For each of those factors identified in A, provide one specific example that applies to TH1 cells. C) What type of pathogens are targeted by the TH1 cells?arrow_forwardIn a mixed lymphocyte reaction, T cells from individual A make a robust response to antigen-presenting-cells from individual B, as long as the two individuals express different alleles of MHC molecules. Estimates indicate that up to 10% of the T cells from individual A may contribute to this response. If one performed this assay using responder T cells from a child and antigen-presenting cells from one parent, the result would be: A massive proliferative response made by the antigen-presenting cells of the parent A very weak response by the child’s T cells, involving only 0.1% of their T cells The complete absence of any proliferative response by the child’s T cells A robust cytolytic response that kills all of the parent’s antigen-presenting cells A robust response by the child’s T cellsarrow_forward
- Surprisingly, humans as well as mice deficient in the complement protein, C3, have greatly reduced antibody responses to T cell-dependent antigens, and are impaired in their ability to control HSV infections. When C3-deficient mice are infected with HSV, once at day 0 and then a second time 4 weeks later, their antibody response is altered compared to wild-type mice, as shown in the figure #3 below. a) What is a likely explanation for the altered antibody response in the absence of complement C3? For fugure #4: For this experiment, mice are infected with varying doses of the HSV-rd virus, and peak IgG responses to the viral surface glycoproteins are measured. The results are shown in the fugure #4. b) What is the most likely explanation for these data? Do these results impact your answer to the part above (a)? Explain your reasoning.arrow_forwardYou are in the process of developing a monoclonal antibody against an Influenza virus spike protein "H7." You have isolated the B cells producing antibodies against the viral H7 protein and fused those specific B cells with a unique kind of mutant myeloma cells. The myeloma cells can't make any of the three following enzymes; dihydrofolate reductase (DHFR), thymidine kinase (TK), and hypoxanthine-guanosine phosphoribosyl transferase (HGPRT). The mutant unfused myeloma cells are grown in the laboratory in a nucleotide supplemented medium. For selecting the hybridomas, you have used a modified medium HT that does not contain any aminopterin but contains hypoxanthine and thymidine. Which of the following result do you expect to see from your experiment, and what problem you may encounter in the future after the hybridoma selection?arrow_forwardSome viruses have mechanisms to down-regulate MHC class I protein expression on the surface of cells in which the virus is replicating. This immune evasion strategy might prevent effector CD8 cytotoxic T cells from recognizing and killing the virus-infected cells. Would this immune evasion strategy also prevent the initial activation of virus-specific CD8 T cells? Yes, because no viral peptide:MHC class I complexes would form to activate CD8 T cells. No, because dendritic cells would take up infected cells and cross-present viral peptides to activate CD8 T cells. No, because some presentation of MHC class I complexes with viral peptides would occur before the virus could down-regulate all the surface MHC class I protein. Yes, because this immune evasion strategy would also function in dendritic cells, even if the virus doesn’t replicate in dendritic cells. No, because the type I interferon response induced by the virus infection will up-regulate MHC class I expression and override the…arrow_forward
arrow_back_ios
SEE MORE QUESTIONS
arrow_forward_ios
Recommended textbooks for you
Human Heredity: Principles and Issues (MindTap Co...BiologyISBN:9781305251052Author:Michael CummingsPublisher:Cengage Learning
Human Physiology: From Cells to Systems (MindTap ...BiologyISBN:9781285866932Author:Lauralee SherwoodPublisher:Cengage Learning
Human Heredity: Principles and Issues (MindTap Co...
Biology
ISBN:9781305251052
Author:Michael Cummings
Publisher:Cengage Learning
Human Physiology: From Cells to Systems (MindTap ...
Biology
ISBN:9781285866932
Author:Lauralee Sherwood
Publisher:Cengage Learning
An Introduction to the Human Genome | HMX Genetics; Author: Harvard University;https://www.youtube.com/watch?v=jEJp7B6u_dY;License: Standard Youtube License